Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Summary

This study is designed as a proof of concept of AIN457 in patients with psoriatic arthritis. The study will address the evaluation of the efficacy at 6 and up to 24 weeks after two doses of AIN457 10 mg/kg administered three weeks apart.

Timeline

Start

2009-03

Primary completion

2010-12

Completion

2010-12

Drugs

Indications